Clinical Trials Browser

Breast Neoplasms, Influenza, Human

NCT06124131 2025-05-04

BENEFIT-C

Vaccine-Preventable Diseases, COVID-19, Vaccination Hesitancy, Influenza, Human, Patient Acceptance of Health Care, Colorectal Neoplasms, Health Behavior

Clinical Trials

VSMART

BENEFIT-C

Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)

Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers

PERIOP-04

Intratumoral Influenza Vaccine for Early Colorectal Cancer

Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors

Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitor

SHIVERING 2

Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors

Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV

IMMUNE

Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia

Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid Tumors

Study of the Immunoresponse in Patients Treated With a Tyrosine Kinase Inhibitor